Advanced technologies in the modern era for augmented patient health care and drug delivery
Abstract
The objective of the work is to recognize the recent advancements in the modern health care and drug delivery systems. The article describes few recent developments in technology like artificial intelligence, personalized medicines, customized medicines, 3D printing, bioelectronic devices and tele pharmacy, which have the potential to augment health care and drug delivery in coming times. Personalized medication ensures precise health care as per the individual genetic makeup of the patients. The 3D printing technology enables to deliver tailor made solutions to fulfil individual patient requirements. Bioelectronic medicines and devices are new technology where the patient wears a device and its electrical signal cures certain ailments. Tele pharmacy ensures that the technological advances of telecommunications are also passed on to the patient health care sector. Moreover, it can be said that all these modern developments ensure that the quality of life improves and there comes a better control on the health care costs.
Keywords: artificial intelligence, personalized medicines, customized medicines, 3D printing, bioelectronic devices and tele pharmacy
Keywords:
artificial intelligence, personalized medicines, customized medicines, 3D printing, bioelectronic devices and tele pharmacy
Downloads
Download data is not yet available.
References
1. Dasta JF. Application of artificial intelligence to pharmacy and medicine. Hosp Pharm 1992; 27:312-5,319-22.
2. Manikiran,, S. S., and Prasanthi, N. L. Artificial Intelligence: Milestones and Role in Pharma and Healthcare Sector. Pharma times 2019; 51:9–56.
3. Warwick, Kevin & Coleman, Kenneth & Leiper, K. & Crook, M. & Andrew, R. & Parsley, K. & Plummer, G. & Clark, D.. Robotics and automation in the pharmaceutical laboratory. 1997; 19:51-54.
4. Ibrić, s. V. E. T. L. A. N. A., parojčić, j. E. L. E. N. A., petrović, j. E. L. E. N. A., and djurić, z. O. R. I. C. A. artificial intelligence in pharmaceutical product formulation: neural computing*. Chemical Industry & Chemical Engineering Quarterly 2009; 25:1–10.
5. Jose, P. A., and Christoper, P. 3D printing of pharmaceuticals – a potential technology in developing personalized medicine. Asian Journal of Pharmaceutical Research and Development 6, 46–54.
6. Scoutaris, N., ROSS, S. A., and Douroumis, D. 3D printed “Starmix” drug loaded dosage forms for paediatric applications,2-19
7. Horst, Diogo. 3D Printing of Pharmaceutical Drug Delivery Systems. Archives of Organic and Inorganic Chemical Sciences. 2018; 1:1-5. 10.32474/AOICS.2018.01.000109.
8. Araújo, M. R. P., Sa-Barreto,, L. L., Gratieri,, T., Gelfuso, G. M., and Cunha-Filho, M. The Digital Pharmacies Era: How 3D Printing Technology Using Fused Deposition Modeling Can Become a Reality. Pharmaceutics 2019; 1–14.
9. Rajiah, Kingston & Venkataraman, R. Tele-pharmacy and E-pharmacy equivocal in India? Technological and legal issues of tele-pharmacy in India. International Journal of Current Pharmaceutical Review and Research. 2015; 6:89-93.
10. Peterson,, C. D., Anderson,, H. C., Bettesworth, L., and Lockyear, M. Telepharmacy. chapter 10 ( Lordan,, D., Davies,, J., and Constable, J., Eds.) 1–35.
11. Skrei, A., and Rundquist, M. M. Pharmacy Services in Telepharmacy: how ’s it working, where it’ s working, and what’ s required to practice in this new setting. Advances in Pharmacy: Journal of Student Solutions to Pharmacy Challenges is published by the University of Minnesota Libraries Publishing. 2017; 1:1–15.
12. Poudel, A., and Nissen, L. M. Telepharmacy: a pharmacist’s perspective on the clinical benefits and challenges. Integrated pharmacy reasearch and practiCE 2016; 1–8.
13. Marlise Araújo dos Santos1,4, Patrícia Bellicanta Lazzarotto1,4, Helena Willhelm de
Oliveira2,4, Júlio César M de Lima3,4 and Thais Russomano, Telepharmacy: The Pharmacy of the 21st Century. SM GROUP 2017; 1–5.
14. Meiliana, A., Dewi, N. M., and Wijaya, A. Personalized Medicine: The Future of Health Care. The Indonesian Biomedical Journal 2016; 8:127–146.
15. Meyer UA.The Potential limits of Personalized medicine: a personal view. Clin Pharmacol Ther. 2012; 373–5.
16. Chouchane, Lotfi & Mamtani, Ravinder & Dallol, Ashraf & Sheikh, Javaid. Personalized Medicine: A Patient - Centered Paradigm. Journal of translational medicine. 2011; 9:206. 10.1186/1479-5876-9-206.
17. Schooneveldt, B. C., Veldwijk, J., and Weda, M. Application of personalized medicine. Ministry of health, welfare and sport 2015; 3–90.
18. Dorey, E. (2016) Acting on the potential of action potentials: will bioelectronic medicines be the next biologics? The Pharmaceutical Journal 1–11.
19. Pavlov, V. A., and Tracey, K. J. Bioelectronic medicine: updates, challenges and paths forward. Pavlov and Tracey Bioelectronic Medicine 2019; 5:1, 1–4.
20. Gordonov T, Kim E, Cheng Y, Ben-Yoav H, Ghodssi R, Rubloff G, Yin JJ, Payne GF, Bentley WE:Electronic modulation of biochemical signal generation. Nat Nanotechnol 2014; 601-610.
21. Olofsson, P. S., and Tracey, K. J. Bioelectronic medicine: technology targeting molecular mechanisms for therapy. The Association for the Publication of the Journal of Internal Medicine Journal of Internal Medicine. 2017.
22. Birmingham, Karen & Gradinaru, Viviana & Anikeeva, Polina & Grill, Warren & Pikov, Victor & McLaughlin, Bryan & Pasricha, Pankaj & Weber, Douglas & Ludwig, Kip & Famm, Kristoffer. Bioelectronic Medicines: A Research Roadmap. Nature Reviews Drug Discovery. 2014; 13. 399. 10.1038/nrd4355.
2. Manikiran,, S. S., and Prasanthi, N. L. Artificial Intelligence: Milestones and Role in Pharma and Healthcare Sector. Pharma times 2019; 51:9–56.
3. Warwick, Kevin & Coleman, Kenneth & Leiper, K. & Crook, M. & Andrew, R. & Parsley, K. & Plummer, G. & Clark, D.. Robotics and automation in the pharmaceutical laboratory. 1997; 19:51-54.
4. Ibrić, s. V. E. T. L. A. N. A., parojčić, j. E. L. E. N. A., petrović, j. E. L. E. N. A., and djurić, z. O. R. I. C. A. artificial intelligence in pharmaceutical product formulation: neural computing*. Chemical Industry & Chemical Engineering Quarterly 2009; 25:1–10.
5. Jose, P. A., and Christoper, P. 3D printing of pharmaceuticals – a potential technology in developing personalized medicine. Asian Journal of Pharmaceutical Research and Development 6, 46–54.
6. Scoutaris, N., ROSS, S. A., and Douroumis, D. 3D printed “Starmix” drug loaded dosage forms for paediatric applications,2-19
7. Horst, Diogo. 3D Printing of Pharmaceutical Drug Delivery Systems. Archives of Organic and Inorganic Chemical Sciences. 2018; 1:1-5. 10.32474/AOICS.2018.01.000109.
8. Araújo, M. R. P., Sa-Barreto,, L. L., Gratieri,, T., Gelfuso, G. M., and Cunha-Filho, M. The Digital Pharmacies Era: How 3D Printing Technology Using Fused Deposition Modeling Can Become a Reality. Pharmaceutics 2019; 1–14.
9. Rajiah, Kingston & Venkataraman, R. Tele-pharmacy and E-pharmacy equivocal in India? Technological and legal issues of tele-pharmacy in India. International Journal of Current Pharmaceutical Review and Research. 2015; 6:89-93.
10. Peterson,, C. D., Anderson,, H. C., Bettesworth, L., and Lockyear, M. Telepharmacy. chapter 10 ( Lordan,, D., Davies,, J., and Constable, J., Eds.) 1–35.
11. Skrei, A., and Rundquist, M. M. Pharmacy Services in Telepharmacy: how ’s it working, where it’ s working, and what’ s required to practice in this new setting. Advances in Pharmacy: Journal of Student Solutions to Pharmacy Challenges is published by the University of Minnesota Libraries Publishing. 2017; 1:1–15.
12. Poudel, A., and Nissen, L. M. Telepharmacy: a pharmacist’s perspective on the clinical benefits and challenges. Integrated pharmacy reasearch and practiCE 2016; 1–8.
13. Marlise Araújo dos Santos1,4, Patrícia Bellicanta Lazzarotto1,4, Helena Willhelm de
Oliveira2,4, Júlio César M de Lima3,4 and Thais Russomano, Telepharmacy: The Pharmacy of the 21st Century. SM GROUP 2017; 1–5.
14. Meiliana, A., Dewi, N. M., and Wijaya, A. Personalized Medicine: The Future of Health Care. The Indonesian Biomedical Journal 2016; 8:127–146.
15. Meyer UA.The Potential limits of Personalized medicine: a personal view. Clin Pharmacol Ther. 2012; 373–5.
16. Chouchane, Lotfi & Mamtani, Ravinder & Dallol, Ashraf & Sheikh, Javaid. Personalized Medicine: A Patient - Centered Paradigm. Journal of translational medicine. 2011; 9:206. 10.1186/1479-5876-9-206.
17. Schooneveldt, B. C., Veldwijk, J., and Weda, M. Application of personalized medicine. Ministry of health, welfare and sport 2015; 3–90.
18. Dorey, E. (2016) Acting on the potential of action potentials: will bioelectronic medicines be the next biologics? The Pharmaceutical Journal 1–11.
19. Pavlov, V. A., and Tracey, K. J. Bioelectronic medicine: updates, challenges and paths forward. Pavlov and Tracey Bioelectronic Medicine 2019; 5:1, 1–4.
20. Gordonov T, Kim E, Cheng Y, Ben-Yoav H, Ghodssi R, Rubloff G, Yin JJ, Payne GF, Bentley WE:Electronic modulation of biochemical signal generation. Nat Nanotechnol 2014; 601-610.
21. Olofsson, P. S., and Tracey, K. J. Bioelectronic medicine: technology targeting molecular mechanisms for therapy. The Association for the Publication of the Journal of Internal Medicine Journal of Internal Medicine. 2017.
22. Birmingham, Karen & Gradinaru, Viviana & Anikeeva, Polina & Grill, Warren & Pikov, Victor & McLaughlin, Bryan & Pasricha, Pankaj & Weber, Douglas & Ludwig, Kip & Famm, Kristoffer. Bioelectronic Medicines: A Research Roadmap. Nature Reviews Drug Discovery. 2014; 13. 399. 10.1038/nrd4355.
Crossmark
Statistics
2512 Views | 685 Downloads
How to Cite
1.
Dev A, Khanra S, Shah N. Advanced technologies in the modern era for augmented patient health care and drug delivery. JDDT [Internet]. 15Jan.2020 [cited 17Apr.2024];10(1):147-52. Available from: https://jddtonline.info/index.php/jddt/article/view/3838
Section
Review
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.